| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/12/2002 | US6355617 Peptide derivatives |
| 03/12/2002 | US6355616 Derivative compounds derived from or based on bactericidal/permeability-increasing protein |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355610 Inhibitors of formation of protease resistant prion protein |
| 03/12/2002 | US6355486 Geenerating genetically engineered microorganism; mix microorganism and preferential nucleotide sequences, electroporate mix, recover genetically engineered microorganism |
| 03/12/2002 | US6355484 Methods and compositions for polypeptides engineering |
| 03/12/2002 | US6355481 Hybridoma cell line and monoclonal antibody for huntingtin protein |
| 03/12/2002 | US6355480 Nucleotide sequences which code preferential protein for use in the treatment of fertility and cell proliferation defects |
| 03/12/2002 | US6355479 Insect polypeptide for use in the treatment of autoimmune diseases, allergies and cancer |
| 03/12/2002 | US6355478 Rhesus monkey neuropeptide Y Y2 receptor |
| 03/12/2002 | US6355477 Fibronectin and fibrinogen binding protein from group A streptococci |
| 03/12/2002 | US6355476 Nucleotide sequences coding animal growth regulator; for use in the treatment of cell proliferation defects; antitumor agents; anticarcinogenic agents |
| 03/12/2002 | US6355473 Yeast cells having mutations in stp22 and uses therefor |
| 03/12/2002 | US6355466 Motor proteins and methods for their use |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355462 Disease resistance factor |
| 03/12/2002 | US6355460 Detecting enzyme inhibitors; incubate enzyme with modulator, monitor sample for reduction in enzyme activity, reduction in enzyme activity indicates modulator |
| 03/12/2002 | US6355459 Genes for the biosynthesis of epothilones |
| 03/12/2002 | US6355458 Nucleotide sequence of hybridized complement; genetic engineering, gene expression; anticarcinogenic agents; sorangium isolates |
| 03/12/2002 | US6355457 Genes for the biosynthesis of epothilones |
| 03/12/2002 | US6355452 Nucleotide sequences which code modulators for use in the treatment of infections, pain, cancers, diabetes, eating, nervous system disorders, asthma, parkinson's, huntington's disease, dyskinesias and gilles dela tourett's syndrome |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355450 Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample |
| 03/12/2002 | US6355425 Diagnosing hemochromatosis or susceptibility in mammals by determining the presence of a missense mutation in exon 2 of an histocompatibility iron loading gene; diagnostic kit |
| 03/12/2002 | US6355424 Detecting induced cell transformation in infected humans by comparing levels of viral early and late mrna genes; increased ratios indicate induced cell transformation and risk of tumors |
| 03/12/2002 | US6355411 Virulence-associated nucleic acid sequences and uses thereof |
| 03/12/2002 | US6355256 Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355253 Bactericidal antibodies |
| 03/12/2002 | US6355252 Antiinflammatory agents |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355246 Feline calicivirus isolated from cat urine and vaccines thereof |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355240 Genetic engineering |
| 03/12/2002 | US6355238 Specific immune system modulation |
| 03/12/2002 | US6355237 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/12/2002 | CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2053799C Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/12/2002 | CA1341347C Androgen receptor proteins, recombinant dna molecules coding for such, and use of such compositions |
| 03/12/2002 | CA1341346C Antisense gene systems of pollination control for hybrid seed production |
| 03/07/2002 | WO2002018955A1 Test for neuropathy by detection of p75ntr |
| 03/07/2002 | WO2002018954A2 Inhibition of cmv infection and dissemination |
| 03/07/2002 | WO2002018938A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 03/07/2002 | WO2002018657A1 Haplotypes of the or11a1 gene |
| 03/07/2002 | WO2002018654A1 Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
| 03/07/2002 | WO2002018651A2 Methods for detecting papillomavirus dna in blood plasma and serum |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018631A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018622A2 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
| 03/07/2002 | WO2002018621A2 Glut10: a novel glucose transporter in the type 2 diabetes linked region of chromosome 20q12-13.1 |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018601A2 Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes' |
| 03/07/2002 | WO2002018600A1 Groes and groel homologs of francisella tularensis |
| 03/07/2002 | WO2002018599A1 Nucleotide sequences coding for the sigm gene |
| 03/07/2002 | WO2002018598A1 Nucleotide sequences which code for the sigh gene |
| 03/07/2002 | WO2002018597A1 Nucleotide sequences which code for the csta gene from corynebacterium glutamicum |
| 03/07/2002 | WO2002018596A1 Citb gene from corynebacteria and use thereof in synthesis of l-amino acids |
| 03/07/2002 | WO2002018595A2 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 03/07/2002 | WO2002018594A1 ZEBRAFISH HuC PROMOTER CAPABLE OF DIRECTING NEURON-SPECIFIC EXPRESSION OF STRUCTURAL GENES, TRANSGENIC ANIMAL HAVING HuC PROMOTER AND ITS GENERATION, AND METHOD FOR SCREENING NEURONAL MUTANT ANIMALS USING THE TRANSGENIC ANIMAL |
| 03/07/2002 | WO2002018592A1 Tumour suppressor gene |
| 03/07/2002 | WO2002018590A2 Identification of activated receptors and ion channels |
| 03/07/2002 | WO2002018589A2 Nucleotide sequence coding for the sigc gene of corynebacterium glutamicum |
| 03/07/2002 | WO2002018588A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018584A2 Xage-1, a gene expressed in multiple cancers, and uses thereof |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018580A2 54372, a novel human anion transporter and uses therefor |
| 03/07/2002 | WO2002018579A2 57242, a novel human g protein-coupled receptor family member and uses therefor |
| 03/07/2002 | WO2002018578A2 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 03/07/2002 | WO2002018577A2 48921, a novel human gtp releasing factor and uses therefor |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018573A2 54370, a novel human sulfate transporter and uses therefor |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018571A2 Human phermone polypeptides |
| 03/07/2002 | WO2002018570A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 03/07/2002 | WO2002018569A2 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | WO2002018568A2 Molecules involved in the regulation of insulin in resistance syndrome (irs) |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018546A2 Plasma-derived-fibrin-based matrices and tissue |
| 03/07/2002 | WO2002018545A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 03/07/2002 | WO2002018538A2 PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS |
| 03/07/2002 | WO2002018536A2 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 03/07/2002 | WO2002018446A2 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018444A2 Erbb4 antagonists |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018439A2 52991, a human transporter protein and uses therefor |
| 03/07/2002 | WO2002018438A1 Modified proteins, isolated novel peptides, and uses thereof |
| 03/07/2002 | WO2002018437A2 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 03/07/2002 | WO2002018436A1 Product and method for control of obesity |